JUPITER, Fla., Jan. 4, 2017 — Somahlution, a global biotechnology company developing products to reduce the burden of ischemia reperfusion injury in tissue grafting, organ transplant and other surgical indications,...

Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry.